+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodiagnostics Market by Product, Indication, End User - Global Forecast 2025-2030- Product Image
Neurodiagnostics Market by Product, Indication, End User - Global Forecast 2025-2030- Product Image
Sale

Neurodiagnostics Market by Product, Indication, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5014094
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurodiagnostics Market grew from USD 7.34 billion in 2023 to USD 7.97 billion in 2024. It is expected to continue growing at a CAGR of 8.71%, reaching USD 13.18 billion by 2030.

Neurodiagnostics encompasses the clinical and technological tools used to diagnose neurological disorders through advanced imaging and monitoring techniques. Its scope extends to various applications including electroencephalography (EEG), electromyography (EMG), and magnetic resonance imaging (MRI), essential for identifying conditions like epilepsy, Alzheimer's, and multiple sclerosis. The necessity for neurodiagnostics is driven by rising incidences of neurological disorders globally, a growing elderly population, and increased demand for early and accurate diagnosis. End-use sectors primarily include hospitals, diagnostic laboratories, and research institutes. Market growth is influenced by technological advancements, increasing healthcare expenditures, and awareness about neurological symptoms and conditions. The integration of artificial intelligence into neurodiagnostic processes for better accuracy and efficiency presents significant potential opportunities. Companies are also urged to capitalize on telehealth trends by offering remote diagnostics solutions that respond to the growing demand for accessible and remote healthcare services.

However, the market faces limitations such as the high costs associated with neurodiagnostic equipment and procedures, regulatory challenges, and a shortage of skilled healthcare professionals capable of operating sophisticated diagnostic machines. Moreover, the complexity of neurological diseases and variability in symptoms add to the challenges of accurate diagnostics. Areas ripe for innovation include the development of portable diagnostic tools and non-invasive techniques that enhance patient comfort while maintaining diagnostic accuracy. Research into personalized medicine through genetic testing and biomarkers can further expand the market. The nature of the neurodiagnostics market is dynamic, with a competitive landscape marked by rapid technological evolution and innovation. Companies aiming for business growth should focus on strategic partnerships and collaborations to enhance technological expertise and expand market reach. Additionally, investing in training programs for healthcare professionals and increasing public awareness of neurological health can mitigate some market challenges, fostering overall growth and improving health outcomes.

Understanding Market Dynamics in the Neurodiagnostics Market

The Neurodiagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidences of neurological disorders worldwide
    • Growing awareness among patients for early disease diagnosis for effective treatment
    • Growing adoption of innovative diagnostic technologies
  • Market Restraints
    • High cost associated with the neurodiagnostic devices
  • Market Opportunities
    • Advances in genomics and proteomics for neurodegenerative disorders diagnosis
    • Ongoing clinical trials for neurological disease
  • Market Challenges
    • Limited availability of skilled healthcare professionals

Exploring Porter’s Five Forces for the Neurodiagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Neurodiagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Neurodiagnostics Market

External macro-environmental factors deeply influence the performance of the Neurodiagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Neurodiagnostics Market

The Neurodiagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Neurodiagnostics Market

The Neurodiagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Neurodiagnostics Market

The Neurodiagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurodiagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Adeor Medical AG, Advanced Brain Monitoring, Inc., Canon Medical Systems USA, Inc., DEYMED Diagnostic s.r.o., F. Hoffmann-La Roche Ltd., GE Healthcare, Koninklijke Philips N.V., Lifelines Neuro Company, LLC, Medtronic PLC, Mitsar Co., Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Siemens Healthineers AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurodiagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Clinical Testing Instrument
      • NGS Instrument
      • PCR Instrument
      • Sanger Sequencer
    • Diagnostic & Imaging System
      • Angiography System
      • CT Scanner
      • EEG System
      • EMG Device
      • MEG Device
      • MRI System
      • PET Scanner
      • Ultrasound Imaging System
    • Reagent & Consumable
      • Antibody
      • Buffer
      • Enzyme, Protein, & Peptide
      • Media & Sera
      • Probe
      • Solvent
  • Indication
    • Epilepsy
    • Headache Disorder
    • Neurodegenerative Diseases
    • Sleep Disorder
    • Stroke
  • End User
    • Ambulatory Care Center
    • Diagnostic Laboratory & Imaging Center
    • Hospital & Clinic
    • Neurology Center
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological disorders worldwide
5.1.1.2. Growing awareness among patients for early disease diagnosis for effective treatment
5.1.1.3. Growing adoption of innovative diagnostic technologies
5.1.2. Restraints
5.1.2.1. High cost associated with the neurodiagnostic devices
5.1.3. Opportunities
5.1.3.1. Advances in genomics and proteomics for neurodegenerative disorders diagnosis
5.1.3.2. Ongoing clinical trials for neurological disease
5.1.4. Challenges
5.1.4.1. Limited availability of skilled healthcare professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Neurodiagnostics Market, by Product
6.1. Introduction
6.2. Clinical Testing Instrument
6.2.1. NGS Instrument
6.2.2. PCR Instrument
6.2.3. Sanger Sequencer
6.3. Diagnostic & Imaging System
6.3.1. Angiography System
6.3.2. CT Scanner
6.3.3. EEG System
6.3.4. EMG Device
6.3.5. MEG Device
6.3.6. MRI System
6.3.7. PET Scanner
6.3.8. Ultrasound Imaging System
6.4. Reagent & Consumable
6.4.1. Antibody
6.4.2. Buffer
6.4.3. Enzyme, Protein, & Peptide
6.4.4. Media & Sera
6.4.5. Probe
6.4.6. Solvent
7. Neurodiagnostics Market, by Indication
7.1. Introduction
7.2. Epilepsy
7.3. Headache Disorder
7.4. Neurodegenerative Diseases
7.5. Sleep Disorder
7.6. Stroke
8. Neurodiagnostics Market, by End User
8.1. Introduction
8.2. Ambulatory Care Center
8.3. Diagnostic Laboratory & Imaging Center
8.4. Hospital & Clinic
8.5. Neurology Center
9. Americas Neurodiagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neurodiagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neurodiagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NEURODIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. NEURODIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NEURODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEURODIAGNOSTICS MARKET DYNAMICS
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PROBE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CANADA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 63. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 64. CANADA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 65. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 69. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 70. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CHINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CHINA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 95. CHINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 96. CHINA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 97. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. INDIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. INDIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 101. INDIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 102. INDIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 103. INDIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 113. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 114. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 149. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 150. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 151. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 155. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 156. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 157. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 166. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 168. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 169. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 174. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 175. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 176. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 180. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 181. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 182. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 186. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 187. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 192. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 193. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 194. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 198. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 199. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 200. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ITALY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. ITALY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 204. ITALY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 205. ITALY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 206. ITALY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. ITALY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 222. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 223. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 224. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. POLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. POLAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 228. POLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 229. POLAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 230. POLAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. POLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. QATAR NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. QATAR NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 234. QATAR NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 235. QATAR NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 236. QATAR NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. QATAR NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 258. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 259. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 260. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 261. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 276. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 277. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 293. NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Neurodiagnostics Market, which are profiled in this report, include:
  • Abbott Laboratories Inc.
  • Adeor Medical AG
  • Advanced Brain Monitoring, Inc.
  • Canon Medical Systems USA, Inc.
  • DEYMED Diagnostic s.r.o.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Lifelines Neuro Company, LLC
  • Medtronic PLC
  • Mitsar Co., Ltd.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.18 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Neurodiagnostic and Monitoring Devices Patent Landscape Report - Product Image

Neurodiagnostic and Monitoring Devices Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From
Neurodiagnostic and Monitoring Devices Market Report and Forecast 2024-2032 - Product Image

Neurodiagnostic and Monitoring Devices Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From

About the Neurodiagnostics Market

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases. The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market. Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.